These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38158206)

  • 21. [Anti-TNF therapy in inflammatory bowel diseases during pregnancy and breast-feeding].
    Persić M
    Acta Med Croatica; 2013 Apr; 67(2):157-64. PubMed ID: 24471298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-IL-12/23p40 antibodies for maintenance of remission in Crohn's disease.
    Davies SC; Nguyen TM; Parker CE; MacDonald JK; Jairath V; Khanna R
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012804. PubMed ID: 31828765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on pregnancy and breastfeeding in the era of biologics.
    Yarur A; Kane SV
    Dig Liver Dis; 2013 Oct; 45(10):787-94. PubMed ID: 23474350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors influencing the outcome of vedolizumab treatment: Real-life data with objective outcome measurements.
    Mader O; Juillerat P; Biedermann L; Michetti P; Hruz P; Pittet V; Rogler G; Zahnd-Straumann N; Seibold F
    United European Gastroenterol J; 2021 Apr; 9(3):398-406. PubMed ID: 33203339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory Bowel Disease in the Childbearing Adult and Newborn.
    Donovan B; Spiel M
    Neoreviews; 2023 Jan; 24(1):10-23. PubMed ID: 36587009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pregnancy outcomes in women with inflammatory bowel disease who successfully conceived via assisted reproduction technique.
    Lavie I; Lavie M; Doyev R; Fouks Y; Azem F; Yogev Y
    Arch Gynecol Obstet; 2020 Sep; 302(3):611-618. PubMed ID: 32529298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pregnancy and breastfeeding in patients with Crohn's disease.
    Mottet C; Juillerat P; Pittet V; Gonvers JJ; Froehlich F; Vader JP; Michetti P; Felley C
    Digestion; 2007; 76(2):149-60. PubMed ID: 18239407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory bowel disease and pregnancy.
    Maliszewska AM; Warska A; Cendrowski K; Sawicki W
    Ginekol Pol; 2017; 88(7):398-403. PubMed ID: 28819946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The safety of vedolizumab in a patient with Crohn's disease who developed anti-TNF-alpha agent associated latent tuberculosis infection reactivation: A case report.
    Sugiyama Y; Ueno N; Tachibana S; Kobayashi Y; Murakami Y; Sasaki T; Sakatani A; Takahashi K; Ando K; Kashima S; Moriichi K; Tanabe H; Okumura T; Fujiya M
    Medicine (Baltimore); 2023 Jul; 102(28):e34331. PubMed ID: 37443475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pregnancy outcome in patients with inflammatory bowel disease according to the activity of the disease and the medical treatment: a case-control study.
    Molnár T; Farkas K; Nagy F; Lakatos PL; Miheller P; Nyári T; Horváth G; Szepes Z; Marik A; Wittmann T
    Scand J Gastroenterol; 2010 Nov; 45(11):1302-6. PubMed ID: 20602569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study.
    Moens A; van der Woude CJ; Julsgaard M; Humblet E; Sheridan J; Baumgart DC; Gilletta De Saint-Joseph C; Nancey S; Rahier JF; Bossuyt P; Cremer A; Dewit S; Eriksson C; Hoentjen F; Krause T; Louis E; Macken E; Milenkovic Z; Nijs J; Posen A; Van Hootegem A; Van Moerkercke W; Vermeire S; Bar-Gil Shitrit A; Ferrante M
    Aliment Pharmacol Ther; 2020 Jan; 51(1):129-138. PubMed ID: 31692017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease.
    Kammerlander H; Nielsen J; Kjeldsen J; Knudsen T; Friedman S; Nørgård B
    Inflamm Bowel Dis; 2017 Jun; 23(6):1011-1018. PubMed ID: 28346274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breastfeeding Patterns in Mothers with Inflammatory Bowel Disease: A Pilot Prospective Longitudinal Study.
    Tandon P; Lee E; Jogendran R; Kroeker KI; Dieleman LA; Halloran B; Wong K; Berga KA; Huang V
    Inflamm Bowel Dis; 2022 Nov; 28(11):1717-1724. PubMed ID: 35099541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammatory bowel disease in pregnancy: a population-based study of prevalence and pregnancy outcomes.
    Shand AW; Chen JS; Selby W; Solomon M; Roberts CL
    BJOG; 2016 Oct; 123(11):1862-70. PubMed ID: 26924786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fecundity, pregnancy outcomes, and breastfeeding in patients with inflammatory bowel disease: a large cohort survey.
    Mañosa M; Navarro-Llavat M; Marín L; Zabana Y; Cabré E; Domènech E
    Scand J Gastroenterol; 2013 Apr; 48(4):427-32. PubMed ID: 23477328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of inflammatory bowel disease and serum level of infliximab in newborn exposed to anti-TNF therapy during pregnancy: Case report and literature review.
    de Aragão MC; Beraldo RF; Marcondes MB; de Barros JR; Herrerias GSP; Saad-Hossne R; Baima JP; Sassaki LY
    Medicine (Baltimore); 2021 Dec; 100(51):e28274. PubMed ID: 34941109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pregnancy with inflammatory bowel disease: Outcomes for mothers and their children at a European tertiary care center.
    Hoffmann P; Krueger J; Bashlekova T; Rupp C; Baumann L; Gauss A
    J Obstet Gynaecol Res; 2022 Mar; 48(3):621-633. PubMed ID: 34935257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety.
    de Lima A; Zelinkova Z; van der Ent C; Steegers EA; van der Woude CJ
    Gut; 2016 Aug; 65(8):1261-8. PubMed ID: 25966992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.